Rein Therapeutics, Inc. SEC filings RNTX
Rein Therapeutics, Inc. has 525 filings in SEC EDGAR's recent list, going back to Dec 3, 2007. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 4, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Jun 8, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Apr 27, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 26, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | May 12, 2025 | Dec 31, 2024 |
| 10-K/A | Amended annual report | Apr 30, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Apr 7, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Jul 9, 2024 | Dec 31, 2023 |
| 10-K/A | Amended annual report | Apr 29, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Apr 15, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Jan 29, 2024 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 20, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 28, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 24, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Mar 30, 2020 | Dec 31, 2019 |
| 10-K/A | Amended annual report | May 8, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 29, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Apr 2, 2018 | Dec 31, 2017 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNTX (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1420565
- Former names
- Aileron Therapeutics, Inc. (until Dec 9, 2024); AILERON THERAPEUTICS INC (until Mar 29, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.